RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Pharmaceutical Industry

A collection of news and information related to Pharmaceutical Industry published by this site and its partners.

Top Pharmaceutical Industry Articles

Displaying items 23-33
  • Japanese firm to buy Avanir Pharmaceuticals for $3.5 billion

    Japanese firm to buy Avanir Pharmaceuticals for $3.5 billion
    Avanir Pharmaceuticals Inc. in Aliso Viejo said Tuesday that it has agreed to be acquired by Japanese drug giant Otsuka Pharmaceutical Co. for about $3.5 billion in cash, the latest in a string of mergers sweeping the healthcare sector. Otsuka, a unit...
  • Energy companies lead an advance in U.S. stocks

    Energy and health-care companies led major stock indexes higher on Tuesday, even as crude oil resumed its slide. General Motors rose after reporting stronger sales, and Biogen, a biotech company, soared following news that its drug for Alzheimer's disease...
  • Japanese firm Otsuka to buy Avanir Pharmaceuticals for $3.5 billion

    The merger wave sweeping the healthcare business caught up another Southern California company Tuesday as Avanir Pharmaceuticals Inc. in Aliso Viejo agreed to be acquired for about $3.5 billion in cash. Japanese drug giant Otsuka Pharmaceutical Co.,...
  • Baxter seeks OK to sell new hemophilia drug

    Baxter International on Monday said it had submitted an application to the Food and Drug Administration for the approval of a key hemophilia drug. The drug, BAX 855, is an extended-release version of its flagship hemophilia drug Advate, which is sold...
  • Allergan is in merger talks with Irish pharmaceutical firm Actavis

    Allergan is in merger talks with Irish pharmaceutical firm Actavis
    Botox maker Allergan Inc. of Irvine, which has spent six months fighting a hostile takeover attempt by a Canadian company, is in increasingly serious discussions to merge with Irish pharmaceutical firm Actavis. If Allergan agrees to be acquired by...
  • Activist investor Bill Ackman wants auction for Allergan

    Activist investor Bill Ackman wants auction for Allergan
    Activist hedge fund manager Bill Ackman on Friday urged Botox maker Allergan Inc. to put itself up for auction. The request follows Allergan’s disclosure that it is in talks to potentially merge with a firm other than the Canadian company Ackman...
  • Though cheered by Wall Street, most mergers don't work out for buyers

    — Wall Street's big business — helping companies buy other companies — is hotter than it's been in years. When pharmaceuticals giant Actavis said it was buying Allergan Inc. in Irvine and Halliburton said it would take over rival oil-...
  • Justice Department, Senate investigating generic drug price hikes

    PHILADELPHIA The 1984 federal law that spawned the generic pharmaceutical industry was designed to use the basic idea of economic competition to lower the cost of prescription medicine for millions of Americans. The law has largely served its intended...
  • Generic drug prices skyrocket in past year

     Generic drug prices skyrocket in past year
    After calling for a routine prescription refill, Craig Elliott got a rude shock: His bill was going up fivefold. The 44-year-old piano tuner and guitar instructor from Elgin, who has health insurance, used to pay $20 for a three-month supply of his...
  • With even some generics rising in price, explore ways to cut your drug costs

    Q: Recently, my doctor prescribed a 10-day course of doxycycline. I always ask for a generic since I need to pay full price. I was shocked when the pharmacist said it would be almost $65. I took this medication three years ago and I think it cost me...
  • Ingredion predicts $8 billion in sales by 2019

     Ingredion predicts $8 billion in sales by 2019
    Ingredion said Tuesday its annual sales should hit $8 billion by 2019, up from $6.33 billion last year, as the ingredients-maker pushes to notch more sales from fast-growing specialty products and international markets. The announcement comes weeks after...